— Know what they know.
Not Investment Advice

600739.SS SHH

Liaoning Cheng Da Co., Ltd.
1W: -2.6% 1M: -8.1% 3M: -0.3% YTD: -15.8% 1Y: -13.6% 3Y: -20.7% 5Y: -47.5%
¥10.21 ($1.52)
+0.13 (+1.29%)
 
SHH · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 30 · ¥15.5B mcap · 840M float · 1.70% daily turnover

Income Trends

Revenue
$11.3B +4.7% ▲
5Y CAGR: -8.6%
Gross Profit
$1.5B +14.9% ▲
5Y CAGR: -10.2%
Operating Income
$752M +413.3% ▲
5Y CAGR: -12.5%
Net Income
$210M -10.1% ▼
5Y CAGR: -29.3%
EPS (Diluted)
$0.14 -8.2% ▼
5Y CAGR: -29.3%
EBITDA
$417M +40.6% ▲
5Y CAGR: -16.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$16.9B$18.4B$14.6B$10.8B$11.3B
YoY Growth-4.5%+8.4%-20.7%-26.0%+4.7%
Cost of Revenue$14.8B$15.8B$12.0B$9.5B$9.8B
Gross Profit$2.1B$2.5B$2.6B$1.3B$1.5B
Gross Margin12.6%13.8%17.8%12.0%13.1%
R&D Expenses$222M$238M$211M$220M$283M
SG&A Expenses$1.4B$1.0B$1.1B$1.1B$1.1B
Operating Expenses-$198M-$100M$872M$1.1B$729M
Operating Income$2.3B$2.6B$1.7B$147M$752M
Operating Margin13.8%14.4%11.8%1.4%6.7%
Interest Expense$609M$662M$653M$6M$674M
Income Before Tax$2.7B$2.6B$1.7B$109M$740M
Tax Expense$186M$145M$260M$121M$75M
Net Income$2.8B$2.2B$1.2B$233M$210M
Net Margin16.4%11.8%8.4%2.2%1.9%
EPS (Diluted)$1.81$1.41$0.80$0.15$0.14
EBITDA$804M$1.6B$1.6B$296M$417M
Shares Outstanding1.53B1.53B1.52B1.55B1.52B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms